Clinical Trials Directory

Trials / Unknown

UnknownNCT01337999

Human Epididymis Protein 4 in Normal Menstruating Women

Status
Unknown
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
Women and Infants Hospital of Rhode Island · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine if Human Epididymis Protein 4 (HE-4) levels vary during the menstrual cycles in ovulatory women. HE-4 is a sensitive serological marker that is elevated in certain ovarian and endometrial cancers and can aid in the diagnosis of these malignant conditions. In order to optimize the utility of HE4 as a tumor marker in premenopausal women, its expression in the normal menstrual cycle needs to be characterized. We hypothesize that HE-4 levels do not vary in the menstrual cycle.

Conditions

Interventions

TypeNameDescription
OTHERblood draws5 blood draws during ovulatory menstrual cycles in premenopausal women

Timeline

Start date
2011-03-01
Primary completion
2014-07-01
First posted
2011-04-19
Last updated
2013-12-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01337999. Inclusion in this directory is not an endorsement.